Handelsbanken Fonder AB Sells 7,712 Shares of HCA Healthcare, Inc. $HCA

Handelsbanken Fonder AB decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.1% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 182,691 shares of the company’s stock after selling 7,712 shares during the period. Handelsbanken Fonder AB’s holdings in HCA Healthcare were worth $71,229,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of HCA. Palisade Asset Management LLC purchased a new position in HCA Healthcare during the third quarter valued at approximately $26,000. Ares Financial Consulting LLC bought a new position in HCA Healthcare in the 4th quarter valued at $31,000. JPL Wealth Management LLC bought a new position in shares of HCA Healthcare in the third quarter worth $33,000. Cedar Mountain Advisors LLC bought a new stake in HCA Healthcare during the first quarter valued at $33,000. Finally, MCF Advisors LLC increased its stake in HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after acquiring an additional 49 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HCA has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on shares of HCA Healthcare in a research report on Monday, July 27th. TD Cowen cut their price objective on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Barclays decreased their price target on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research note on Monday, July 27th. Truist Financial lowered their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research note on Monday, July 27th. Finally, Wells Fargo & Company increased their price objective on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a report on Monday, August 3rd. Fourteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $465.59.

HCA Healthcare Stock Up 0.1%

HCA Healthcare stock opened at $413.78 on Tuesday. The stock’s 50 day moving average is $389.86 and its 200 day moving average is $448.25. The company has a market capitalization of $89.58 billion, a P/E ratio of 13.85, a PEG ratio of 1.44 and a beta of 1.10. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the previous year, the company posted $6.84 earnings per share. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, equities analysts expect that HCA Healthcare, Inc. will post 29.45 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.45%.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.